Archive · 29 Sep 2026
Aster DM Quality Care Targets Expansion; Motilal Oswal Sees Upside
Aster DM Healthcare and Quality Care India joined together to form a large hospital company.
The new company operates 39 hospitals in 28 Indian cities.
It currently has about 10,600 beds for patients.
The company believes it can grow to more than 15,000 beds by FY30.
Motilal Oswal, a brokerage, recommended buying the stock.
It set a target price of Rs 910, which it says is 22% higher than the current level.
The brokerage expects the merger to save money and help hospitals send patients to one another.
However, slower integration, expansion delays, or new rules could hurt the company’s profits.
The merger created Aster DM Quality Care, with 39 hospitals and about 10,600 operational beds across 28 cities.
Motilal Oswal initiated coverage with a Buy recommendation and a Rs 910 target price, implying 22% upside.
The merged platform could scale beyond 15,000 beds by FY30 through cluster-led expansion and new additions.
Motilal expects revenue to grow at a 19.5% CAGR between FY26 and FY28, reaching Rs 13,200 crore.
Key risks include delayed synergies, expansion delays, regulatory changes, and price caps affecting profitability.
- Who
- Aster DM Healthcare and Quality Care India, now operating as Aster DM Quality Care, along with brokerage Motilal Oswal.
- What
- The merged hospital platform received a Buy recommendation and Rs 910 target price from Motilal Oswal.
- When
- Motilal Oswal’s forecasts cover FY26-FY28, while the platform’s expansion target extends to FY30.
- Where
- The platform operates across 28 cities in India, with major regional exposure to Kerala, Karnataka, Maharashtra, Andhra Pradesh, and Telangana.
- Why
- The brokerage expects regional diversification, hospital expansion, merger synergies, and scale benefits to support growth.
Growth Case
Risk Case
Merger synergies
Growth Case
Centralised procurement, supply-chain optimisation, shared clinical resources, and corporate cost reductions could improve margins and operating leverage.
Risk Case
Delays in realising synergies could weigh on margins and reduce the expected benefits of the merger.
Capacity expansion
Growth Case
The platform could exceed 15,000 beds by FY30, supported by cluster-led growth, the 454-bed Trivandrum expansion, and other additions.
Risk Case
Expansion delays could defer growth and weaken return on capital employed.
Profit outlook
Growth Case
Motilal Oswal projects strong revenue, EBITDA, and net-profit growth through FY28, supported by diversification and higher scale.
Risk Case
Regulatory changes and price caps could pressure profitability, while the merged entity’s net debt is higher than before the merger.
- Merged entity
- Aster DM Quality Care
- Hospital network
- 39 hospitals across 28 cities
- Operational beds
- Approximately 10,600
- FY30 capacity potential
- More than 15,000 beds
- Motilal Oswal rating
- Buy
- Target price
- Rs 910, implying 22% upside
- Net debt after merger
- Rs 11.6 billion, compared with a pre-merger cash surplus of Rs 5 billion